Previous Article | Next Article ![]()
J. Virol., 01 1995, 23-31, Vol 69, No. 1
I Najera, A Holguin, ME Quinones-Mateu, MA Munoz-Fernandez, R Najera, C Lopez- Galindez and E Domingo
The nucleotide sequences of two pol gene regions (codons 41 to 108 and 181
to 219 of reverse transcriptase) of 60 human immunodeficiency virus type 1
genomes obtained directly from primary lymphocytes from infected
individuals are reported. In addition, the mutant spectra of several
quasispecies have been sampled by repetitive sequencing of molecular clones
representing the same pol genomic regions. Average mutation frequencies
ranged from 1.6 x 10(-2) to 3.4 x 10(-2) substitutions per nucleotide for
independent samples (relative to their consensus nucleotide sequence) and
from 3.6 x 10(-3) to 1.1 x 10(-2) substitutions per nucleotide for
individual quasispecies distributions. Several mutations leading to amino
acid substitutions related to loss of sensitivity to reverse transcriptase
inhibitors have been identified in samples from patients not subjected to
antiretroviral therapy. Mutation frequencies in the codons previously
identified as involved in resistance to reverse transcriptase inhibitors
were very similar to the average mutation frequencies in the pol region
analyzed. Thus, the finding of mutations related to drug resistance (even
in the absence of positive selection by the corresponding drugs) is the
expected consequence of the statistical distribution of mutations along the
pol gene. The presence of such critical amino acid replacements in human
immunodeficiency virus type 1 populations underscores the importance of
viral quasispecies as reservoirs of phenotypic virus variants and has a
number of implications for AIDS control.
Copyright © 1995, American Society for Microbiology
Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy
Centro de Biologia Molecular Severo Ochoa (Consejo Superior de Investigaciones Cientificas-UAM, Universidad Autonoma de Madrid, Spain.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|